BiotechTube
Home/Contera Pharma/Thomas Sager
TS

Thomas Sager

CEO

Contera Pharma

Therapeutic Areas

Neurological Disorders

Contera Pharma Pipeline

DrugIndicationPhase
CP-012Nocturnal immobility and morning akinesia in Parkinson's diseasePhase 1b
CP-102Canavan diseasePreclinical